First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with Psoriasis.
about
Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-CA Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis.A review on interleukins: The key manipulators in rheumatoid arthritis.Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis
P2860
First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with Psoriasis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
First-In-Human, Phase 1, Rando ...... dy in Patients with Psoriasis.
@ast
First-In-Human, Phase 1, Rando ...... dy in Patients with Psoriasis.
@en
type
label
First-In-Human, Phase 1, Rando ...... dy in Patients with Psoriasis.
@ast
First-In-Human, Phase 1, Rando ...... dy in Patients with Psoriasis.
@en
prefLabel
First-In-Human, Phase 1, Rando ...... dy in Patients with Psoriasis.
@ast
First-In-Human, Phase 1, Rando ...... dy in Patients with Psoriasis.
@en
P2093
P2860
P1433
P1476
First-In-Human, Phase 1, Rando ...... dy in Patients with Psoriasis.
@en
P2093
Alice B Gottlieb
Brett E Skolnick
James G Krueger
Marie Göthberg
Mia Sandberg Lundblad
P2860
P304
P356
10.1371/JOURNAL.PONE.0134703
P407
P577
2015-08-07T00:00:00Z